1Cattaneo MG,Amoroso D,Gussoni G,et al.A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines [J].FEBS Lett,1996,397:164.
2Woltering EA,Watson JC,Alperin Lea PC,et al.Somatostatin analogs: Angiogenesis inhibitors with novel mechanisms of action [J].Invest New Drugs,1997,15:77.
3Georgii-Hemming BP,Stromberg T,Janson ET,et al.The somatostatin analog octreotide inhibits growth of interleukin-6 (IL-6)-dependent and IL-6-independent human multiple myeloma cell lines [J].Blood,1999,93(5):1724-1731.
4Solary E,Dubrez L,Eymin B.The role of apoptosis the pathogenesis and treatment of disease [J].Eur Respir J,1996,9:1293-1297.
5Oltvai ZN,Milliman CL,Korsmeyer SJ.Bcl-2 heterodimerizes in vivo with a conserved hemology,Bax,that accelerates programmed cell death [J].Cell,1993,74:609-615.
2Strowski MZ,Parmar RM,Blake AD,et al.Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes:an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice[J].Endocrinology,2000,141(3)∶111-117.
3Lopez F,Ferjoux G,Cordelier P,et al.Neuronal nitric oxide synthase:a substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling[J].FASEB J,2001,15(5):2300-2302.
5Vantus T,Keri G,Krivickiene Z,et al.The somatostatin analogue TT-232 induces apoptosis in A431 cells:sustained activation of stress-activated kinases and inhibition of signalling to extracellular signal regulated kinases[J].Cell Signal,2001,13(2)∶717-725
6Dalm VA,van Hagen PM,van Koetsveld PM,et al.Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system[J].J Clin Endocrinol Metab,2003,88(16)∶270-276.
